C. Vu

Target of Rapamycin Signaling in Leukemia and Lymphoma

D. Fruman, C. Vu, David A. Fruman, 2010, Clinical Cancer Research.

Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor

Jing Chen, Marina Konopleva, Yi Liu, 2010, Nature Medicine.

Differential Involvement of Initiator Caspases in Apoptotic Volume Decrease and Potassium Efflux during Fas- and UV-induced Cell Death*

C. Bortner, J. Cidlowski, C. C. Vu, 2001, The Journal of Biological Chemistry.

Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia

C. Rommel, D. Fruman, M. Lilly, 2013, Leukemia.